longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Weekly Recap | IMAX +2.5%, most brokers rate it buy

Weekly Review
Sep 5, 2026 at 07:06 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

IMAX rose 2.5% this week to close at $51.64, while the S&P 500 edged up 0.09%, putting the stock ahead of the benchmark by about 2.41 percentage points. Trading was choppy but upward biased: gains on Monday, Wednesday and Thursday were interrupted by a small pullback on Tuesday, and Friday’s intraday high of $53.165 was followed by a slight fade. The weekly range ran from $50.39 to $53.165.

The Week

IMAX rose 2.5% this week to close at $51.64, while the S&P 500 edged up 0.09%, putting the stock ahead of the benchmark by about 2.41 percentage points. Trading was choppy but upward biased: gains on Monday, Wednesday and Thursday were interrupted by a small pullback on Tuesday, and Friday’s intraday high of $53.165 was followed by a slight fade. The weekly range ran from $50.39 to $53.165.

Key Events

On Tuesday, reports said IMAX was exploring a sale following a record quarter, alongside news that VNET had partnered with CATL on infrastructure. The broader market found support later in the week from the jobs report and big tech, with the Dow posting its best day since early August. Over the weekend, an article argued IMAX may be about 10% undervalued, with cash flow partly offsetting its rich earnings multiple.

Analyst Ratings

Eleven brokers cover IMAX: seven rate it buy, two rate it over or outperform, and two are neutral, with no sell or under ratings. The consensus rating is buy, and the consensus target of $55.65 sits about 7.8% above the latest close of $51.64. Targets range widely from $45.00 to $69.19, pointing to real disagreement among brokers. Within the film and entertainment industry, IMAX ranks 15th out of 43 rated names.

The Week Ahead

Next week brings the NFIB small-business sentiment reading, initial jobless claims, final-demand PPI, existing home sales, wholesale sales data and a 10-year Treasury auction. Attention is likely to stay on how macro data shapes risk appetite, while IMAX has no earnings on the calendar and any fresh news on the reported sale exploration may be the key watch item.

In Short

IMAX outperformed the index this week and the consensus rating skews positive, but the wide target range reflects genuine disagreement, and the stock trades around 69 times earnings. The latest session’s flows show small-lot money turning net seller. From here, the tension sits between the stock’s premium valuation and its cash-flow story, with macro data and any sale-related headlines as the next things to watch.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock1,694characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

IMAX

IMAX

IMAX.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI